Earnings History Data for Assertio Holdings, Inc. (ASRT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Assertio Holdings, Inc.
Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 09-05-2023 | PM | Before the open (May 9) |
ASRT | Assertio Holdings, Inc. | 342.34 | -0.07 | 0.13 | 0.20 | Assertio Therapeutics Non-GAAP EPS of $0.29 beats by $0.07, revenue of $42.47M beats by $4.83M [5/9/2023 7:19 AM] |
7.00 | 0.74 (11.74%) |
6.81 | 0.55 (8.79%) |
1.86 - 7.33 | 6,517,514 | 3,050,000 | 439,646 | |
| 08-03-2023 | AH | 4:00 PM ET (Mar 8) |
ASRT | Assertio Holdings, Inc. | 258.37 | 1.34 | 0.23 | 0.10 | Assertio Therapeutics Non-GAAP EPS of $0.32 beats by $0.12, revenue of $50.35M beats by $2.91M [3/8/2023 4:04 PM] |
6.66 | 0.70 (11.66%) |
5.95 | -0.01 (-0.17%) |
1.86 - 7.00 | 5,427,740 | 3,160,000 | 16,770 | |
| 08-11-2022 | AH | 4:00 PM ET (Nov 8) |
ASRT | Assertio Holdings, Inc. | 127.67 | 0.08 | 0.07 | 0.08 | Assertio Therapeutics Non-GAAP EPS of $0.22 beats by $0.11, revenue of $34.21M beats by $2.86M [11/8/2022 4:26 PM] |
2.66 | 0.04 (1.53%) |
2.80 | 0.18 (6.87%) |
1.19 - 4.44 | 1,531,891 | 840,000 | 47,138 | |
| 08-08-2022 | PM | 8:30 AM ET (Aug 8) |
ASRT | Assertio Holdings, Inc. | 141.30 | 0.16 | 0.08 | -0.32 | 3.65 | -0.34 (-8.65%) |
4.40 | 0.41 (10.28%) |
0.85 - 4.44 | 2,686,458 | 1,600,000 | 137,293 | ||
| 09-05-2022 | AH | 4:00 PM ET (May 9) |
ASRT | Assertio Holdings, Inc. | 95.20 | 0.20 | 0.09 | 0.12 | Assertio Therapeutics Non-GAAP EPS of $0.38, revenue of $36.54M beats by $3.48M [5/9/2022 4:39 PM] |
2.20 | 0.32 (17.02%) |
2.12 | 0.24 (12.77%) |
0.85 - 3.52 | 1,851,024 | 540,000 | 86,699 | |
|
||||||||||||||||||
| 09-03-2022 | PM | 6:00 AM ET (Mar 9) |
ASRT | Assertio Holdings, Inc. | 101.32 | 0.10 | 0.12 | -0.80 | Assertio Therapeutics GAAP EPS of $0.10 misses by $0.02, revenue of $33.33M beats by $2.56M [3/9/2022 8:56 AM] |
2.58 | 0.41 (18.58%) |
2.26 | 0.08 (3.67%) |
0.85 - 4.12 | 863,517 | 440,000 | 25,996 | |
|
||||||||||||||||||
| 04-11-2021 | AH | 4:00 PM ET (Nov 4) |
ASRT | Assertio Holdings, Inc. | 50.72 | 0.08 | -0.04 | -0.36 | Assertio Therapeutics EPS beats by $0.24, beats on revenue [11/4/2021 4:03 PM] |
1.48 | 0.37 (32.88%) |
1.27 | 0.16 (14.41%) |
0.85 - 5.80 | 13,581,437 | 1,190,000 | 3,702,391 | |
| 05-08-2021 | AH | 4:00 PM ET (Aug 5) |
ASRT | Assertio Holdings, Inc. | 58.22 | -0.32 | -0.08 | -1.40 | Assertio Therapeutics EPS misses by $0.24, beats on revenue; raises full year guidance [8/5/2021 4:20 PM] |
1.25 | -0.08 (-6.01%) |
1.35 | 0.02 (1.50%) |
1.15 - 5.80 | 1,069,440 | 490,000 | 20,449 | |
| 06-05-2021 | AH | 4:00 PM ET (May 6) |
ASRT | Assertio Holdings, Inc. | 91.39 | 0.03 | -0.01 | 0.58 | Assertio Therapeutics EPS beats by $0.04, beats on revenue [5/6/2021 4:31 PM] |
0.57 | 0.07 (14.30%) |
0.62 | 0.12 (24.32%) |
0.33 - 1.45 | 21,032,676 | 4,530,000 | 11,001,241 | |
|
||||||||||||||||||
| 11-03-2021 | AH | 4:00 PM ET (Mar 11) |
ASRT | Assertio Holdings, Inc. | 151.55 | -0.20 | -0.04 | -2.65 | Assertio Therapeutics EPS misses by $0.16, beats on revenue [3/11/2021 4:02 PM] |
0.9799 | 0.03 (2.94%) |
0.9150 | -0.04 (-3.88%) |
0.33 - 1.45 | 11,561,482 | 14,887,544 | 335,858 | |
| 06-11-2020 | PM | 6:00 AM ET (Nov 6) |
ASRT | Assertio Holdings, Inc. | 69.75 | -0.09 | -0.05 | 0.05 | Assertio Therapeutics EPS misses by $0.05, beats on revenue [11/6/2020 6:03 AM] |
0.48 | -0.19 (-28.36%) |
0.66 | -0.01 (-1.49%) |
0.45 - 1.71 | 3,686,648 | 257,374 | 27,098 | |
|
|
||||||||||||||||||
| 07-08-2020 | PM | 8:00 AM ET (Aug 7) |
ASRT | Assertio Holdings, Inc. | 95.00 | -0.35 | -0.12 | -0.21 | Assertio Therapeutics EPS misses by $0.23, misses on revenue [8/7/2020 6:05 AM] |
0.79 | -0.14 (-15.51%) |
0.8577 | -0.08 (-8.27%) |
0.55 - 2.92 | 3,138,530 | 623,835 | 127,120 | |
|
|
||||||||||||||||||